BioSig Technologies, Inc. Common Stock
BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States. The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of… Read more
Market Cap & Net Worth: BioSig Technologies, Inc. Common Stock (BSGM)
BioSig Technologies, Inc. Common Stock (OTCQB:BSGM) has a market capitalization of $18.16 Million ($18.16 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #27335 globally and #9162 in its home market, demonstrating a -12.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BioSig Technologies, Inc. Common Stock's stock price $0.52 by its total outstanding shares 35270900 (35.27 Million).
BioSig Technologies, Inc. Common Stock Market Cap History: 2015 to 2025
BioSig Technologies, Inc. Common Stock's market capitalization history from 2015 to 2025. Data shows change from $1.14 Billion to $18.16 Million (-36.65% CAGR).
Index Memberships
BioSig Technologies, Inc. Common Stock is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #719 of 976 |
Weight: BioSig Technologies, Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
BioSig Technologies, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BioSig Technologies, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1578.37x
BioSig Technologies, Inc. Common Stock's market cap is 1578.37 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.38 Billion | $118.00K | -$52.17 Million | 11657.33x | N/A |
| 2021 | $786.54 Million | $441.00K | -$31.36 Million | 1783.54x | N/A |
| 2022 | $148.14 Million | $286.00K | -$27.27 Million | 517.96x | N/A |
| 2023 | $167.54 Million | $18.00K | -$29.04 Million | 9307.60x | N/A |
| 2024 | $63.13 Million | $40.00K | -$10.33 Million | 1578.37x | N/A |
Competitor Companies of BSGM by Market Capitalization
Companies near BioSig Technologies, Inc. Common Stock in the global market cap rankings as of March 19, 2026.
Key companies related to BioSig Technologies, Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
BioSig Technologies, Inc. Common Stock Historical Marketcap From 2015 to 2025
Between 2015 and today, BioSig Technologies, Inc. Common Stock's market cap moved from $1.14 Billion to $ 18.16 Million, with a yearly change of -36.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $18.16 Million | -71.23% |
| 2024 | $63.13 Million | -62.32% |
| 2023 | $167.54 Million | +13.10% |
| 2022 | $148.14 Million | -81.17% |
| 2021 | $786.54 Million | -42.82% |
| 2020 | $1.38 Billion | -34.12% |
| 2019 | $2.09 Billion | +38.64% |
| 2018 | $1.51 Billion | +18.60% |
| 2017 | $1.27 Billion | +11.64% |
| 2016 | $1.14 Billion | -0.39% |
| 2015 | $1.14 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BioSig Technologies, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.16 Million USD |
| MoneyControl | $18.16 Million USD |
| MarketWatch | $18.16 Million USD |
| marketcap.company | $18.16 Million USD |
| Reuters | $18.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.